Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Etofenamate 50 mg/g; ;
Viatris Limited
Etofenamate 50 mg/g
5% w/w
Topical gel
Active: Etofenamate 50 mg/g Excipient: Carbomer Ethanol Isopropyl alcohol Macrogol 400 Purified water Sodium hydroxide
Tube, 50 g
Pharmacy only
Pharmacy only
Duke-Chem S A
For the external supportive symptomatic treatment of pain: · caused by active strains, sprains or bruises in the extremities after blunt trauma such as sport injuries · in soft tissue near a joint (e.g.bursa, tendon, cord and joint capsule) in cases of gonarthrosis
Package - Contents - Shelf Life: Tube, - 50 g - 60 months from date of manufacture stored at or below 30°C
1995-03-08
NEW ZEALAND CONSUMER MEDICINE INFORMATION RHEUMON ® GEL 1 g of gel contains 50 mg of etofenamate. For use in adults. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. THIS MEDICINE IS AVAILABLE WITHOUT PRESCRIPTION. HOWEVER, YOU STILL NEED TO USE RHEUMON GEL CAREFULLY TO GET THE BEST RESULTS FROM IT. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. You must contact a doctor if your symptoms worsen or do not improve after three days. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Rheumon Gel is and what it is used for 2. Before you use Rheumon Gel 3. How to use Rheumon Gel 4. Possible side effects 5. How to store Rheumon Gel 6. Further information 1. WHAT RHEUMON GEL IS AND WHAT IT IS USED FOR Rheumon Gel is a medicine for external, local application. Etofenamate, the active substance in Rheumon Gel, belongs to the group of the non- steroidal (cortisone-free) anti-rheumatics (rheumatism cure) and has anti-inflammatory (antiphlogistic) and pain-relieving (analgesic) properties. USES For the external supportive symptomatic treatment of pain: caused by acute strains, sprains or bruises in the limbs after blunt injuries such as sports injuries; in soft tissue near a joint (e.g. bursa, tendon, cord and joint capsule) in cases of arthrosis of the knee. DO NOT USE RHEUMON GEL FOR LONGER THAN 3 DAYS WITHOUT CHECKING WITH YOUR DOCTOR. 2. BEFORE YOU USE RHEUMON GEL DO NOT USE RHEUMON GEL, if you are allergic (hypersensitive) to etofenamate, flufenamic acid, any of the other ingredients of Rheumon Gel or to any other pain reliever or rheumatic cure (non- steroidal anti-inflammatory agents); on open injuries, inflammations or infections of the skin as well as on skin eczema or on mucous membranes. in the last trimester of pregnancy. in children and adolescents. TAKE SPECIAL CARE WITH R Read the complete document
Page 1 of 7 NEW ZEALAND DATA SHEET RHEUMON 1. PRODUCT NAME Rheumon, 5% w/w, topical gel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g of topical gel contains 50 mg of etofenamate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Nearly transparent yellowish gel for topical application. 4. CLINICAL PARTICULARS _4.1 _ _THERAPEUTIC INDICATIONS_ For the external supportive symptomatic treatment of pain in adults: caused by acute strains, sprains or bruises in the extremities after blunt trauma such as sports injuries; in soft tissue near a joint (e.g. bursa, tendon, cord and joint capsule) in cases of gonarthrosis. If symptoms persist for longer than 3 days, a doctor must be consulted. _4.2_ _DOSE AND METHOD OF ADMINISTRATION_ DOSE Apply Rheumon Gel three times a day. Depending on the size of the painful areas, an about 5 to 10 cm long ribbon (equivalent to about 1.7 to 3.3 g of gel and 75 to 150 mg of etofenamate) will be required. For treatment of blunt trauma, the maximum daily dose is 9 g of gel, equivalent to 450 mg of etofenamate. METHOD OF ADMINISTRATION Only for external application to the skin. Do not ingest. Apply Rheumon Gel in a thin layer on the affected parts of the body and gently rub into the skin. Before applying a dressing, Rheumon Gel should be left for a few minutes to dry on the skin. The application of an occlusive dressing is not recommended. Page 2 of 7 Usually, treatment for one week is sufficient. Therapeutic benefit of a longer use has not been verified. _4.3_ _CONTRAINDICATIONS_ Rheumon Gel should not be used in the following cases: Hypersensitivity to etofenamate, flufenamic acid, other non-steroidal anti-inflammatory drugs or to any of the excipients listed in section 6.1. On open injuries, inflammations or infections of the skin as well as on skin eczema or on mucous membranes. Third trimester of pregnancy. Children and adolescents, as clinical experience is limited. _4.4_ _SPECIAL WARNINGS AND PRECAUTIONS FOR USE_ Rheumon Gel should not Read the complete document